MAP1LC3A Gene

Introduction

Pathway Diagram

flowchart TD
    LC3["LC3<br/>(Autophagy Marker)"]
    
    Autophagy["Autophagy<br/>Process"]
    Autophagosome["Autophagosome<br/>Formation"]
    Protein_Agg["Protein<br/>Aggregation"]
    
    AD["Alzheimer's<br/>Disease"]
    PD["Parkinson's<br/>Disease"]
    ALS["Amyotrophic Lateral<br/>Sclerosis"]
    MS["Multiple<br/>Sclerosis"]
    
    Neurodegeneration["Neurodegeneration<br/>Process"]
    Dementia["Dementia<br/>Phenotype"]
    Ischemia["Cerebral<br/>Ischemia"]
    
    Atherosclerosis["Atherosclerosis<br/>Vascular Disease"]
    
    Cell_Death["Neuronal<br/>Cell Death"]
    Neuroprotection["Neuroprotective<br/>Mechanisms"]
    
    LC3 -->|"essential for"| Autophagy
    LC3 -->|"forms"| Autophagosome
    Autophagy -->|"degrades"| Protein_Agg
    
    LC3 -->|"activates"| Neurodegeneration
    LC3 -->|"associated with"| AD
    LC3 -->|"associated with"| PD
    LC3 -->|"activates"| ALS
    LC3 -->|"activates"| MS
    
    Neurodegeneration -->|"leads to"| Cell_Death
    LC3 -->|"activates"| Dementia
    LC3 -->|"activates"| Ischemia
    
    LC3 -->|"inhibits"| Atherosclerosis
    Autophagy -->|"promotes"| Neuroprotection
    
    AD -->|"contributes to"| Dementia
    PD -->|"contributes to"| Dementia
    
    style LC3 fill:#006494
    style Autophagy fill:#1b5e20
    style Autophagosome fill:#1b5e20
    style Neuroprotection fill:#1b5e20
    style Neurodegeneration fill:#ef5350
    style Cell_Death fill:#ef5350
    style AD fill:#5d4400
    style PD fill:#5d4400
    style ALS fill:#5d4400
    style MS fill:#5d4400
    style Dementia fill:#5d4400
    style Protein_Agg fill:#4a1a6b
    style Ischemia fill:#ef5350
    style Atherosclerosis fill:#ef5350

Map1Lc3A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

:: infobox .infobox-gene ^{1"Autophagy-independent function of MAP1LC3 family proteins." *Autophagy* (2018)2018 · Autophagy · PMID 29257353Open reference} Symbol: MAP1LC3A ^{2"Promoting the clearance of neurotoxic proteins in neurodegenerative disorders." *Nature Reviews Neurology* (2018)2018 · Nature Reviews Neurology · PMID 29980754Open reference} Full Name: Microtubule Associated Protein 1 Light Chain 3 Alpha ^{3"The role of autophagy in neurodegenerative disease." *Nature Medicine* (2013)2013 · Nature Medicine · PMID 23921753Open reference} Chromosomal Location: 20q11.22 ^{4"Autophagy regulation by LC3 family proteins in neurodegenerative diseases." *Cell Death & Disease* (2022)2022 · Cell Death & Disease · PMID 35654814Open reference} NCBI Gene ID: 9455 ^{5"Lysosomal proteolysis inhibition causes selective accumulation of autophagosomes in Alzheimer's disease." *Nature* (2010)2010 · Nature · PMID 20445626Open reference} OMIM: 609453 ^{6"The impairment of autophagy as a pathological mechanism in Alzheimer's disease." *Molecular and Cellular Neurosciences* (2011)2011 · Molecular and Cellular Neurosciences · PMID 21893245Open reference} Ensembl ID: ENSG00000101460 ^{7"LRRK2 and autophagic dysfunction in Parkinson's disease." *Neurobiology of Disease* (2022)2022 · Neurobiology of Disease · PMID 35247688Open reference} UniProt: Q9Y488 ^{8"Spatial parkin entanglement in mitochondrial quality control." *Trends in Neurosciences* (2014)2014 · Trends in Neurosciences · PMID 24429115Open reference} Proteins: LC3A ^{9"Polyglutamine disease: when aggregation goes awry." *Neuron* (2017)2017 · Neuron · PMID 28577976Open reference} Associated Diseases: Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, ALS ::

Overview

MAP1LC3A (Microtubule-Associated Protein 1 Light Chain 3 Alpha) encodes LC3A, a fundamental protein in the autophagy pathway. LC3A is a member of the LC3/GABARAP family, which are ubiquitin-like proteins essential for autophagosome formation and cargo recruitment. The MAP1LC3A gene produces multiple isoforms through alternative splicing, with LC3A being widely expressed in neural tissue. This protein plays critical roles in neuronal homeostasis, protein quality control, and cellular stress responses—all processes central to neurodegenerative disease pathogenesis.

Molecular Function

Autophagosome Biogenesis

LC3A undergoes post-translational processing to become functional. The precursor LC3 is first cleaved by ATG4B to generate LC3-I, which is then conjugated to phosphatidylethanolamine (PE) by the ATG7/ATG3 system to form LC3-II (lipidated LC3). LC3-II is directly integrated into the expanding autophagosome membrane, where it serves multiple essential functions:

• Membrane recruitment: LC3-II anchors to the growing phagophore membrane through its lipid moiety

• Cargo recognition: LC3A interacts with selective autophagy receptors (p62/SQSTM1, OPTN, NDP52) that recognize ubiquitinated cargo

• Fusion facilitation: LC3A facilitates autophagosome-lysosome fusion through interactions with the HOPS complex and LAMP proteins

• ER contact sites: LC3A localizes to ER-mitochondria contact sites and ER-phagophore contact sites

Homologs and Family

The LC3/GABARAP family includes:

• LC3A (MAP1LC3A), LC3B (MAP1LC3B), LC3C (MAP1LC3C)

• GABARAP, GABARAPL1, GABARAPL2/GATE-16

These proteins have overlapping but distinct functions in autophagy.

Expression Pattern

LC3A exhibits tissue-specific expression:

Brain

• Neurons throughout cortex, hippocampus, basal ganglia, and cerebellum

• Astrocytes and oligodendrocytes

• Highest expression in regions with active protein turnover: hippocampus CA1 pyramidal cells, cerebellar Purkinje cells

Peripheral Tissues

• Heart, liver, kidney, lung, pancreas

• Skeletal muscle

• Immune cells (macrophages, dendritic cells)

Disease Associations

Alzheimer’s Disease

LC3A and autophagy are implicated in AD through multiple mechanisms:

1. Amyloid clearance: Autophagy normally degrades Aβ; impaired LC3A function leads to Aβ accumulation

2. Tau pathology: Autophagy dysfunction contributes to tau aggregation and spread

3. Synaptic vulnerability: LC3A-mediated selective autophagy of synaptic proteins is disrupted in AD

4. Neuronal loss: Defective autophagy in vulnerable neurons precedes clinical symptoms

Research shows decreased LC3A expression in AD brain tissue, correlating with cognitive decline.

Parkinson’s Disease

LC3A is central to PD pathogenesis:

1. Alpha-synuclein clearance: Selective autophagy via LC3A-p62 removes abnormal α-synuclein

2. Mitophagy: PINK1/Parkin-mediated mitophagy uses LC3A for damaged mitochondrion elimination

3. LRRK2 interaction: G2019S LRRK2 mutation impairs autophagic flux

4. Dopaminergic neuron vulnerability: High metabolic demand makes neurons dependent on LC3A-mediated quality control

Huntington’s Disease

1. Mutant huntingtin clearance: LC3A-mediated selective autophagy removes mutant HTT aggregates

2. Transcriptional dysregulation: LC3A interacts with transcription factors including REST

3. Neuronal dysfunction: Autophagy impairment contributes to progressive neurodegeneration

Amyotrophic Lateral Sclerosis (ALS)

1. Protein aggregate clearance: LC3A helps remove TDP-43, SOD1, FUS aggregates

2. Stress granules: LC3A localizes to stress granules; prolonged stress leads to toxic aggregation

3. Axonal transport: LC3A-dependent autophagy maintains axonal homeostasis

Therapeutic Implications

Autophagy Modulation

1. LC3A activators: Small molecules enhancing LC3A lipidation (e.g., rapamycin analogs)

2. ATG4B modulators: Inhibitors to prevent LC3A delipidation and stabilize autophagosomes

3. Gene therapy: Viral vectors delivering functional MAP1LC3A to enhance autophagy

Selective Autophagy Enhancement

1. p62/OPTN agonists: Enhance selective autophagy of protein aggregates

2. Mitophagy inducers: Target PINK1/Parkin pathway to enhance mitochondrial clearance

3. ER-phagophore contact modulation: Improve early autophagosome formation

Combination Approaches

1. Autophagy + anti-aggregation: Combined autophagy enhancement with Aβ/α-synuclein immunotherapies

2. Neuroprotective compounds: Flavonoids and polyphenols that upregulate LC3A expression

3. Lifestyle interventions: Caloric restriction and exercise that enhance neuronal autophagy

Research Directions

Biomarkers

• LC3A expression levels in CSF as a biomarker for autophagic flux

• LC3A puncta in neurons as a marker of autophagy induction

See Also

• Autophagy Pathway

• Mitophagy in Neurodegeneration

• Protein Aggregation

• LC3A Protein

• Gene index

Background

The study of Map1Lc3A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• PubMed - Biomedical literature

• Alzheimer’s Disease Neuroimaging Initiative - Research data

• Allen Brain Atlas - Brain gene expression data